{
  "retracted": false,
  "timestamp": 1583971200000,
  "updates": [
    {
      "timestamp": 1591764181441,
      "identifier": {
        "doi": "10.1177/1758835920913426"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1177/1758835919889001"
  },
  "journal": "Therapeutic Advances in Medical Oncology",
  "publisher": "SAGE Publications",
  "title": "Erratum to A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma"
}
